INCHEON, Korea--(BUSINESS WIRE)-- #Biosimilar--Samsung Bioepis Co., Ltd. and Epis NexLab Co., Ltd.,

Generation Bio Co. (NASDAQ: GBIO - Get Free Report) has earned an average rating of "Hold" from the

Generation Bio Co. (NASDAQ: GBIO - Get Free Report) has been assigned an average rating of "Hold" fr

MILWAUKEE , Dec. 15, 2025 /PRNewswire/ -- The Ademi Firm is investigating Generation Bio (Nasdaq: GB

NEW YORK--(BUSINESS WIRE)--Halper Sadeh LLC, an investor rights law firm, is investigating whether t

- Acquisition provides XOMA Royalty with potential milestone and royalty payments under Generation B

CAMBRIDGE, Mass., Nov. 05, 2025 (GLOBE NEWSWIRE) -- Generation Bio Co. (Nasdaq: GBIO), a biotechnolo

Generation Bio (NASDAQ: GBIO - Get Free Report) and Nuvation Bio (NYSE: NUVB - Get Free Report) are

• Geoff McDonough, MD to step down as CEO & President and become Chair of the Company's Board of Dir

Shares of Sapiens International Corporation NV (NASDAQ:SPNS) rose sharply in pre-market trading afte

Generation Bio Co. (GBIO) came out with a quarterly loss of $3.12 per share versus the Zacks Consens

• New data confirm highly selective profile of cell-targeted lipid nanoparticle (ctLNP) and first-ev

CAMBRIDGE, Mass., July 18, 2025 (GLOBE NEWSWIRE) -- Generation Bio Co. (Nasdaq: GBIO), a biotechnolo

CAMBRIDGE, Mass., July 07, 2025 (GLOBE NEWSWIRE) -- Generation Bio Co. (Nasdaq:GBIO), a biotechnolog

Squarepoint Ops LLC purchased a new position in Generation Bio Co. (NASDAQ:GBIO – Free Report)

CAMBRIDGE, Mass., May 28, 2025 (GLOBE NEWSWIRE) -- Generation Bio Co. (Nasdaq:GBIO), a biotechnology

Generation Bio Co. (GBIO) came out with a quarterly loss of $0.22 per share versus the Zacks Consens

-  Company continues to advance its strategy to develop first-in-class treatments for T cell-driven

CAMBRIDGE, Mass., April 02, 2025 (GLOBE NEWSWIRE) -- Generation Bio Co. (Nasdaq:GBIO), a biotechnolo

Generation Bio Co. (GBIO) came out with a quarterly loss of $0.32 per share versus the Zacks Consens

-  Company is applying its T cell-selective lipid nanoparticle to develop siRNA therapeutics for T c

Gainers

  On Thursday, 148 companies set new 52-week lows.

Bloomberg

The collapse of SVB Financial Group (NASDAQ: SIVB) could have a ripple effect on the technology and

    On Wednesday, 348 companies hit new 52-week lows.

    On Friday, 313 companies hit new 52-week lows.

    On Thursday, 147 companies achieved new lows for the year.

    During Monday's session, 291 companies made new 52-week lows. Also check out this: Insid

    On Friday, 106 companies reached new 52-week lows.

Gainers Synthetic Biologics, Inc. (NYSE: SYN) shares climbed 100% to close at $1.00 on Tuesday af

  During Wednesday's morning trading, 70 companies set new 52-week highs.

  Tuesday's morning session saw 195 companies set new 52-week highs.

  This morning 230 companies reached new 52-week highs.

  This morning 180 companies set new 52-week highs.